What is the appropriate emergency management for a 54-year-old male with uncontrolled diabetes, blood glucose 365 mg/dL, four days of dizziness, nausea, vomiting, and who has missed insulin and GLP‑1 therapy for one week?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Emergency Management: Hyperglycemic Crisis with Suspected DKA or HHS

This patient requires immediate emergency department evaluation for a hyperglycemic crisis—specifically diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS)—given the blood glucose of 365 mg/dL, one week of missed insulin/GLP-1 therapy, and acute symptoms of nausea, vomiting, and dizziness.

Immediate Assessment Required

Check ketones immediately (blood beta-hydroxybutyrate preferred over urine ketones) to differentiate between DKA and HHS, as this determines ICU-level care needs 1. The clinical presentation—missed insulin for one week with GI symptoms—strongly suggests a hyperglycemic emergency rather than simple hyperglycemia.

Critical Laboratory Tests Needed STAT:

  • Blood glucose (already 365 mg/dL = 20.3 mmol/L)
  • Venous blood gas (arterial not necessary initially) for pH and bicarbonate
  • Serum ketones (beta-hydroxybutyrate) or urine ketones
  • Complete metabolic panel including sodium, potassium, chloride, bicarbonate, BUN, creatinine
  • Calculated serum osmolality to assess for HHS (>320 mOsm/L indicates HHS)
  • Anion gap calculation
  • Phosphate and calcium

2, 3

Treatment Algorithm Based on Ketone Results

If Ketonemia ≥1.5 mmol/L or Ketonuria ≥2+:

Transfer to ICU for continuous IV insulin infusion 1. This indicates DKA or mixed DKA/HHS requiring intensive monitoring.

Fluid resuscitation is the priority:

  • Start with 0.9% normal saline at 15-20 mL/kg/hour for the first 1-2 hours (approximately 1-1.5 L for most adults)
  • Never use hypotonic fluids initially 4
  • Transition to 0.45% saline once hemodynamically stable and sodium is normal/elevated
  • Add dextrose (D5W) to IV fluids once glucose falls to 200-250 mg/dL to prevent hypoglycemia while continuing insulin to clear ketones 2

Insulin therapy:

  • Continuous IV insulin infusion at 0.1 units/kg/hour (no initial bolus needed in most protocols)
  • Target glucose reduction of 50-75 mg/dL per hour
  • Do not stop insulin until ketones clear, even if glucose normalizes—continue insulin with dextrose-containing fluids 2, 3

Potassium replacement is critical:

  • Check potassium before starting insulin
  • If K+ <3.3 mEq/L: hold insulin and give potassium first
  • If K+ 3.3-5.0 mEq/L: add 20-30 mEq potassium to each liter of IV fluid
  • Monitor potassium every 2-4 hours (hypokalaemia occurs in ~50% during treatment and increases mortality) 3

If Ketonemia 0.5-1.5 mmol/L or Ketonuria 1+:

Give 6 units rapid-acting insulin subcutaneously and recheck glucose and ketones in 3 hours 1. Start aggressive IV hydration with 0.9% saline. If ketones worsen or glucose remains >300 mg/dL, escalate to ICU-level continuous insulin infusion.

If No Ketosis (Ketonemia <0.5 mmol/L, Ketonuria 0):

Suspect HHS, especially given the patient's age (54 years) and Type 2 diabetes profile (on GLP-1 therapy). HHS has 10-fold higher mortality than DKA 5.

  • Check serum osmolality urgently: >320 mOsm/L confirms HHS 1
  • Clinical signs: profound dehydration, altered mental status (dizziness may indicate early confusion), no significant acidosis
  • Requires ICU admission for aggressive fluid resuscitation (often 6-10 L deficit)
  • Start subcutaneous rapid-acting insulin 6 units and initiate IV hydration 1
  • May still require IV insulin infusion if glucose remains severely elevated

Critical Pitfalls to Avoid

  1. Do not rely on glucose level alone to distinguish DKA from HHS—glucose of 365 mg/dL can occur in either condition. The presence/absence of ketones and degree of acidosis are diagnostic 6, 5.

  2. Do not stop IV insulin when glucose normalizes in DKA—ketone clearance lags behind glucose correction. Continue insulin with dextrose-containing fluids until ketones resolve (pH >7.3, bicarbonate >18 mEq/L) 2.

  3. Monitor for cerebral edema during treatment, though more common in children. Avoid overly rapid correction of glucose and osmolality 2.

  4. The missed GLP-1 therapy is relevant: GLP-1 agonists slow gastric emptying, and their sudden discontinuation may have contributed to poor glycemic control, but the primary issue is missed insulin causing absolute insulin deficiency 7.

Resolution Criteria Before Discharge

For DKA resolution 2:

  • Glucose <200 mg/dL
  • Serum bicarbonate ≥18 mEq/L
  • Venous pH >7.3
  • Anion gap normalized

Transition from IV to subcutaneous insulin: Give first dose of subcutaneous basal insulin 1-2 hours before stopping IV insulin to prevent rebound hyperglycemia 3, 8.

Post-Acute Management

Once stabilized, calculate total daily insulin requirement from the IV infusion rate over the last 12-24 hours. Give approximately 50% as basal insulin (long-acting) and divide the remainder as prandial doses (rapid-acting) with meals 1.

Address medication non-adherence: This is the most common precipitating factor for recurrent DKA in established diabetes 4, 9. Arrange immediate diabetes education, assess financial barriers to insulin access, and ensure close follow-up within 1-2 weeks 10, 8.

The 4 days of dizziness preceding acute symptoms suggests progressive metabolic decompensation—this was not a sudden event but rather evolving hyperglycemic crisis from prolonged insulin omission.

Related Questions

In a diabetic patient non‑adherent to therapy with a blood glucose of 500 mg/dL but without diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS), how should this episode be classified and why does it require hospital admission?
How does diabetic ketoacidosis develop, what role do infection or sepsis play as precipitants, what are common triggers, and how does it differ from hyperosmolar hyperglycemic state in type 2 diabetes?
How should severe hyperglycemia with a capillary blood glucose of 652 mg/dL be managed emergently?
What is the appropriate management for a 71-year-old woman with type 2 diabetes, severe hyperglycemia (blood glucose 460 mg/dL), modest ketoacidosis (ketones 5.23 mmol/L, anion gap 20 mmol/L, bicarbonate 22 mmol/L, venous pH 7.35), high serum osmolarity (315 mOsm/kg), creatinine 0.99 mg/dL, eGFR 61 mL/min/1.73 m², history of pancreatitis and alcohol use, currently taking glipizide, and hemoglobin A1c 13.1%?
Can you explain step‑by‑step the presentation, diagnosis, and management of hypoglycemia, diabetic ketoacidosis, and hyperosmolar hyperglycemic state?
Can aspirin be administered to a patient with chest pain who has a do-not-resuscitate (DNR) order?
What are the health benefits of regular exercise?
Why does pembrolizumab cause diabetic ketoacidosis (DKA)?
How should diltiazem be administered and dosed for acute rate control of atrial fibrillation and for chronic therapy?
What are the possible causes of frontal headaches in a 71‑year‑old patient and what initial work‑up should be performed?
What dose of activated charcoal should be given for a patient who ingested fipronil 0.05% gel?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.